Cartherics Pty ltd products

This technology involves induced pluripotential stem cell (iPSC) derived NK cells (and, potentially, other types of immune cells). iPSCs have unlimited capacity for self-renewal.

This technology arms the patient’s own T cells with CARs, which enable them to “seek and destroy” cancer cells.

Indication: Other TAG-72* tumors. Research: iNK cells [TAG-72 CAR + gene KO].

Indication: TAG-72 tumors . Research: CTH-401 + additional gene KOs.

Indication: Solid tumors. Research: Descriptor iNK cells [other CAR targets / dual CARs].